The Amateur Traders Corner Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Amateur Traders Corner

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul A who wrote (14443)	10/2/2001 10:04:23 PM
From: Tom Hua	Read Replies (3) of 19633

Paul, BioPort, a private company in Lansing Michigan, and the sole supplier of anthrax vaccine in the U.S. received over 1000 calls in the past week inquiring about procurement of the vaccine and if the company is publicly traded. Because of the vast amount of calls, the company has now left a recorded message to answer these FAQs. Sooner or later (and I think it's sooner) similar interest in smallpox vaccine will draw tremendous interest to BREL, the principal supplier of the vaccine to the DoD and CDC. With a float of 1.7 million shares and much of that reside in the hands of sub 5% institutional owners, I can't wait for high volume days. Regards, Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next